|
Magneto-electronic Sensing of Cancer in Urine
|
1R43CA221535-01
|
$220,000
|
$220,000
|
SANG, LIYUN
|
ACCURE HEALTH, INC.
|
|
Novel IL-15 Superagonist Therapy for Bladder Cancer
|
2R44CA156740-04
|
$999,919
|
$999,919
|
WONG, HING
|
ALTOR BIOSCIENCE CORPORATION
|
|
MACHINE LEARNING METHODS TO IDENTIFY BLADDER CANCER CASES MISSED BY ROUTINE SURVEILLANCE
|
261201700515P
|
$24,500
|
$24,500
|
UNKNOWN, UNKNOWN
|
BANERJEE, MOUSUMI
|
|
Cancer-associated fibroblast in the regulation of bladder cancer stem cells
|
5R01CA175397-05
|
$324,738
|
$324,738
|
CHAN, KEITH SYSON
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
$3,550
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
$3,566
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
$3,668
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
$7,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
$97,594
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Racial Disparity in Bladder Cancer and Identification of Altered Metabolism in African American Compare to European Bladder Cancer
|
1R01CA220297-01
|
$370,749
|
$370,749
|
PUTLURI, NAGIREDDY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Sh3gl2 and chemosensitivity of bladder cancer
|
5R21CA198722-02
|
$209,985
|
$209,985
|
ADAM, ROSALYN
|
BOSTON CHILDREN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-04S1
|
$2,088,480
|
$41,770
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-04
|
$11,145,123
|
$222,902
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Analyzing Complex Cancer Studies With Skewed Responses
|
5R03CA205018-02
|
$83,299
|
$83,299
|
LIPSITZ, STUART
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
3U10CA180853-04S1
|
$76,498
|
$1,912
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
5U10CA180853-04
|
$1,188,450
|
$29,711
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
FrostBite-BC - A New Thermal Ablation Device for Treating Bladder Cancer
|
1R43CA210761-01A1
|
$308,550
|
$308,550
|
BAUST, J
|
CELL PRESERVATION SERVICES, INC.
|
|
Cancer Center Support Grant
|
3P30CA013696-43S1
|
$120,000
|
$2,400
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S2
|
$60,000
|
$1,200
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S3
|
$118,652
|
$2,373
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S4
|
$199,541
|
$3,991
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-43
|
$3,792,720
|
$75,854
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Investigating the cell of origin for bladder cancer
|
5R01CA193442-03
|
$474,774
|
$474,774
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Systematic Identification and Pharmacological Targeting of Tumor Dependencies for Precision Cancer Medicine
|
1U01CA217858-01
|
$1,164,547
|
$232,909
|
CALIFANO, ANDREA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
SEER: Infrastructure Support and Patterns of Care/Quality of Care Study
|
261201300019I
|
$2,787,357
|
$418,104
|
UNKNOWN, UNKNOWN
|
CONNECTICUT STATE DEPT OF PUBLIC HEALTH
|
|
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
|
5U10CA180867-04
|
$1,302,199
|
$48,832
|
BURSTEIN, HAROLD
|
DANA-FARBER CANCER INST
|
|
Investigating the effect of ERCC2 mutations on DNA repair capacity and chemo-radiotherapy response in muscle-invasive bladder cancer
|
1K08CA219504-01
|
$177,120
|
$177,120
|
MOUW, KENT
|
DANA-FARBER CANCER INST
|
|
(PQ3) Immune epigenetic biomarkers of bladder cancer outcomes
|
1R01CA216265-01
|
$632,860
|
$632,860
|
CHRISTENSEN, BROCK
|
DARTMOUTH COLLEGE
|
|
Dartmouth Lead Participation in NCI National Clinical Trials Network
|
5U10CA180854-04
|
$357,058
|
$17,853
|
DRAGNEV, KONSTANTIN
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-38S1
|
$100,606
|
$4,024
|
LEACH, STEVEN
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-38S2
|
$124,999
|
$5,000
|
LEACH, STEVEN
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-38S3
|
$45,000
|
$1,800
|
LEACH, STEVEN
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-38S4
|
$47,801
|
$1,912
|
LEACH, STEVEN
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
5P30CA023108-38
|
$3,189,824
|
$127,593
|
LEACH, STEVEN
|
DARTMOUTH COLLEGE
|
|
NCI National Clinical Trials Network U10
|
5U10CA180857-04
|
$392,946
|
$9,824
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
ECOG-ACRIN Operations Center
|
3U10CA180820-04S1
|
$394,013
|
$7,880
|
COMIS, ROBERT
|
ECOG-ACRIN MEDICAL RESEARCH FOUNDATION
|
|
ECOG-ACRIN Operations Center
|
5U10CA180820-04
|
$11,276,830
|
$225,537
|
O'DWYER, PETER
|
ECOG-ACRIN MEDICAL RESEARCH FOUNDATION
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-04
|
$542,798
|
$20,355
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
SEER: Infrastructure Support and Patterns of Care/Quality of Care Study
|
261201300015I
|
$2,824,187
|
$423,628
|
UNKNOWN, UNKNOWN
|
EMORY UNIVERSITY
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-04
|
$637,150
|
$31,858
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
SEER: Infrastructure Support and Patterns of Care/Quality of Care Study
|
261201300012I
|
$4,364,042
|
$654,606
|
UNKNOWN, UNKNOWN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Evaluation of dynamic strategies of cancer care
|
1K99CA207730-01A1
|
$137,137
|
$45,255
|
GARCIA DE ALBENIZ, XABIER
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
SEER: Infrastructure Support and Patterns of Care/Quality of Care Study
|
261201300009I
|
$1,414,528
|
$212,179
|
UNKNOWN, UNKNOWN
|
HAWAII UNIV
|
|
Understanding barriers to single-dose intravesical chemotherapy in non-muscle invasive bladder cancer
|
5K23CA212272-02
|
$143,543
|
$143,543
|
CARY, KELLY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Building upon a tradition of excellence. The NCTN at Indiana University
|
5U10CA180795-04
|
$519,002
|
$15,570
|
MILLER, KATHY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Building sustainable and innovative research in Cancer and Cardiovascular disease: Planning the design and development of the South American Center of Research Excellence to Counter NCDs (SACREN)
|
1P20CA217231-01
|
$249,500
|
$124,750
|
Irazola, Vilma
|
INSTITUTO DE EFECTIVIDAD CLINICA Y SANIT
|
|
Diet and Lifestyle in a Prospective Study of Bladder Cancer Survivors
|
5R01CA172855-04
|
$982,302
|
$982,302
|
KWAN, MARILYN
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
$91,664
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
SEER: Infrastructure Support and Patterns of Care/Quality of Care Study
|
261201300016I
|
$1,864,684
|
$279,703
|
UNKNOWN, UNKNOWN
|
LSU HEALTH SCIENCES CENTER
|
|
Translation of a Clinical Molecular Diagnostic Assay for Bladder Cancer
|
1R01CA206584-01A1
|
$618,256
|
$618,256
|
GOODISON, STEVE
|
MAYO CLINIC JACKSONVILLE
|
Total relevant funding to Bladder for this search: $35,665,315
|